Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
Yasumura Y, Miyatake K, Okamoto H, Miyauchi T, Kawana M, Tsutamoto T, Kitakaze M, Matsubara H, Takaoka H, Anzai T, Himeno H, Yokoyama H, Yokoya K, Shintani U, Hashimoto K, Koretsune Y, Nakamura Y, Imai K, Maruyama S, Masaoka Y, Sekiya M, Shiraki T, Shinohara H, Ozono K, Matsuoka T, Miyao Y, Nomura F.
Yasumura Y, et al.
Circ J. 2004 Apr;68(4):361-6. doi: 10.1253/circj.68.361.
Circ J. 2004.
PMID: 15056835
Free article.
Clinical Trial.